Respiration Disorders  >>  oxelumab (RG4930)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxelumab (RG4930) / Roche, Genmab
NCT00983658: A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

Completed
2
29
Canada
huMAb OX40L, placebo
Genentech, Inc.
Asthma
08/10
01/11

Download Options